Of the 123 CP‐MS at baseline, 100 people with MS (81.3%) were still CP at 5‐year follow‐up, 14 people (11.4%) converted to MCI, and nine (7.3%) to CI. This evidence concerns the gene CP and myeloid sarcoma.